Prognostic impact of number of examined lymph nodes on survival of patients with appendiceal neuroendocrine tumors

被引:2
作者
Du, Rui [1 ]
Xiao, Jiang-Wei [1 ,2 ]
机构
[1] First Affiliated Hosp, Chengdu Med Coll, Dept Gastrointestinal Surg, Chengdu 610500, Sichuan, Peoples R China
[2] First Affiliated Hosp, Chengdu Med Coll, Dept Gastrointestinal Surg, 278 Baoguang Ave, Chengdu 610500, Sichuan, Peoples R China
关键词
Appendiceal neoplasm; Neuroendocrine tumors; Carcinoid tumor; Lymph node dissection; Lymph node ratio; Survival analysis; ENETS CONSENSUS GUIDELINES; CARCINOID-TUMORS; APPENDECTOMY SPECIMENS; MANAGEMENT; NEOPLASMS; DIAGNOSIS; OUTCOMES; ILEUM; RATIO;
D O I
10.12998/wjcc.v10.i30.10906
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND The prognosis of patients with appendiceal neuroendocrine tumors (ANETs) is related to lymph node (LN) metastasis and other factors. However, it is unclear how the number of examined LNs (ELNs) impact on survival. AIM To determine the factors affecting the cancer-specific survival (CSS) of patients with ANET and to evaluate the impact of the number of ELNs on survival. METHODS A total of 4583 ANET patients were analyzed in the Surveillance, Epidemiology, and End Results database. Univariate survival analysis was used to identify factors related to survival and the optimal number of ELNs and lymph node ratio (LNR) were determined by the Kaplan-Meier method. The survival difference was determined by CSS. RESULTS Except for sex, the other factors, such as age, year, race, grade, histological type, stage, tumor size, ELNs, LNR, and surgery type, were associated with prognosis. The 3-, 5-, and 10-year CSS rates of ANET patients were 91.2%, 87.5, and 81.7%, respectively (median follow-up period of 31 mo and range of 0-499 mo). There was no survival difference between the two surgery types, namely, local resection and colectomy or greater, in both stratifications of tumor size >= 2 cm (P = 0.523) and < 2 cm (P = 0.068). In contrast to patients with a tumor size < 2 cm, those with a tumor size >= 2 cm were more likely to have LN metastasis (chi(2 )= 378.16, P < 0.001). The optimal number of ELNs was more than 11, 7, and 18 for all patients, node-negative patients, and node-positive patients, respectively. CSS rates of patients with a larger number of ELNs were significantly improved (<= 10 vs >= 11, chi(2 )= 20.303, P < 0.001; <= 6 vs >= 7, chi(2 )= 11.569, P < 0.001; <= 17 vs >= 18, chi(2 )= 21.990, P < 0.001; respectively). ANET patients with an LNR value <= 0.16 were more likely to have better survival than those with values of 0.17-0.48 (chi(2 )= 48.243, P < 0.001) and 0.49-1 (chi(2 )= 168.485, P < 0.001). CONCLUSION NET >= 2 cm are more likely to develop LN metastasis. At least 11 ELNs are required to better evaluate the prognosis. For patients with positive LN metastasis, 18 or more LNs need to be detected and lower LNR values (LNR <= 0.16) indicate a better survival prognosis.
引用
收藏
页码:10906 / 10920
页数:15
相关论文
共 41 条
  • [1] Abdelaal A, 2017, ANN MED SURG, V21, P20, DOI 10.1016/j.amsu.2017.07.043
  • [2] Gastrointestinal neuroendocrine tumors in 2020
    Ahmed, Monjur
    [J]. WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2020, 12 (08) : 791 - 807
  • [3] Unusual histopathological findings in appendectomy specimens: A retrospective analysis and literature review
    Akbulut, Sami
    Tas, Mahmut
    Sogutcu, Nilgun
    Arikanoglu, Zulfu
    Basbug, Murat
    Ulku, Abdullah
    Semur, Heybet
    Yagmur, Yusuf
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2011, 17 (15) : 1961 - 1970
  • [4] Is right hemicolectoray for 2.0-cm appendiceal carcinoids justified?
    Bamboat, ZM
    Berger, DL
    [J]. ARCHIVES OF SURGERY, 2006, 141 (04) : 349 - 352
  • [5] The NANETS Consensus Guideline for the Diagnosis and Management of Neuroendocrine Tumors Well-Differentiated Neuroendocrine Tumors of the Jejunum, Ileum, Appendix, and Cecum
    Boudreaux, J. Philip
    Klimstra, David S.
    Hassan, Manal M.
    Woltering, Eugene A.
    Jensen, Robert T.
    Goldsmith, Stanley J.
    Nutting, Charles
    Bushnell, David L.
    Caplin, Martyn E.
    Yao, James C.
    [J]. PANCREAS, 2010, 39 (06) : 753 - 766
  • [6] Morphological Factors Related to Nodal Metastases in Neuroendocrine Tumors of the Appendix A Multicentric Retrospective Study
    Brighi, Nicole
    La Rosa, Stefano
    Rossi, Giulio
    Grillo, Federica
    Pusceddu, Sara
    Rinzivillo, Maria
    Spada, Francesca
    Tafuto, Salvatore
    Massironi, Sara
    Faggiano, Antongiulio
    Antonuzzo, Lorenzo
    Santini, Donatella
    Sessa, Fausto
    Maragliano, Roberta
    Gelsomino, Fabio
    Albertelli, Manuela
    Vernieri, Claudio
    Panzuto, Francesco
    Fazio, Nicola
    De Divitiis, Chiara
    Lamberti, Giuseppe
    Colao, Annamaria
    Delle Fave, Gianfranco
    Campana, Davide
    [J]. ANNALS OF SURGERY, 2020, 271 (03) : 527 - 533
  • [7] Incidence and survival trends for gastric neuroendocrine neoplasms: An analysis of 3523 patients in the SEER database
    Cao, Long-Long
    Lu, Jun
    Lin, Jian-Xian
    Zheng, Chao-Hui
    Li, Ping
    Xie, Jian-Wei
    Wang, Jia-Bin
    Chen, Qi-Yue
    Lin, Mi
    Tu, Ru-Hong
    Huang, Chang-Ming
    [J]. EJSO, 2018, 44 (10): : 1628 - 1633
  • [8] Carr NJ., 2009, SURG PATHOLOGY GI TR, VSecond, pp639
  • [9] The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM
    Edge, Stephen B.
    Compton, Carolyn C.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (06) : 1471 - 1474
  • [10] Colon Cancer
    Engstrom, Paul F.
    Arnoletti, Juan Pablo
    Benson, Al B., III
    Chen, Yi-Jen
    Choti, Michael A.
    Cooper, Harry S.
    Covey, Anne
    Dilawari, Raza A.
    Early, Dayna S.
    Enzinger, Peter C.
    Fakih, Marwan G.
    Fleshman, James, Jr.
    Fuchs, Charles
    Grem, Jean L.
    Kiel, Krystyna
    Knol, James A.
    Leong, Lucille A.
    Lin, Edward
    Mulcahy, Mary F.
    Rao, Sujata
    Ryan, David P.
    Saltz, Leonard
    Shibata, David
    Skibber, John M.
    Sofocleous, Constantinos
    Thomas, James
    Venook, Alan P.
    Willett, Christopher
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2009, 7 (08): : 778 - 831